Regeneron Pharmaceuticals, Inc. (REGN) stock analysis

Regeneron Pharmaceuticals, Inc. is a global biopharmaceutical enterprise focused on discovering, inventing, developing, manufacturing, and bringing to market medical treatments for a wide array of illnesses. Its therapeutic portfolio includes EYLEA, an injection used to treat various ophthalmic conditions such as wet age-related macular degeneration, diabetic macular edema, myopic choroidal neovascularization, diabetic retinopathy, and macular edema resulting from retinal vein occlusion (both central and branch). Other significant offerings are Dupixent, an injectable solution for atopic de…

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology

trefolio is not a financial advisor. Market data and AI narratives are for informational purposes only and may contain errors. Past performance does not guarantee future results. This is not investment advice.